Iris Palme

Mannheim, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Primary CD34+ cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243.

Primary CD34+ cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243.

Journal: British journal of haematology

Published: June 17, 2025

Machine learning-based in-silico analysis identifies signatures of lysyl oxidases for prognostic and therapeutic response prediction in cancer.

Machine learning-based in-silico analysis identifies signatures of lysyl oxidases for prognostic and therapeutic response prediction in cancer.

Journal: Cell communication and signaling : CCS

Published: September 25, 2024

Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.

Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.

Journal: Annals of hematology

Published: December 19, 2023

Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell level.

Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell level.

Journal: Blood neoplasia

Published: December 13, 2023

ASXL1 mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms.

ASXL1 mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms.

Journal: Haematologica

Published: February 09, 2023

In Silico Pan-Cancer Analysis Reveals Prognostic Role of the Erythroferrone (ERFE) Gene in Human Malignancies.

In Silico Pan-Cancer Analysis Reveals Prognostic Role of the Erythroferrone (ERFE) Gene in Human Malignancies.

Journal: International journal of molecular sciences

Published: December 06, 2022

Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies.

Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies.

Journal: Nature communications

Published: July 15, 2022

Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium.

Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium.

Journal: Stem cell research & therapy

Published: June 03, 2022

Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes.

Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes.

Journal: Experimental hematology

Published: April 07, 2021

Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes.

Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes.

Journal: Leukemia

Published: February 15, 2021

Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo.

Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo.

Journal: Nature communications

Published: January 26, 2021

High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes.

High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes.

Journal: British journal of haematology

Published: October 11, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026